Journal Information
Vol. 47. Issue 8.
Pages 821-833 (October 2024)
Vol. 47. Issue 8.
Pages 821-833 (October 2024)
Original article
A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study)
Una dosis adicional de vacuna contra el SARS-CoV-2 mejora la tasa subóptima de seroconversión en pacientes con enfermedad inflamatoria intestinal. Resultados de un estudio multicéntrico de GETECCU (estudio VACOVEII)
Diego Casas Deza, Ana Belén Julián Gomara, Eva Caudevilla Biota, Belén Beltrán, Eugeni Domènech, Ana Gutiérrez Casbas, Miriam Mañosa, Yamile Zabana, Lourdes Roc Alfaro, Emilio Valverde Romero, Elena García González, Beatriz Sicilia, Viviana Laredo, Maria José Alcalá Escriche, Lucia Madero Velázquez, Rocío Ferreiro-Iglesias, Antonia Palmero Pérez, Margalida Calafat, Saioa Rubio Iturria, Irene Moraleja Yudego..., Yolanda Ber Nieto, Sandra García Mateo, Javier P. Gisbert, Raquel Vicente Lidón, Lara Arias, Erika Alfambra, Ana Belén Doñate Borao, Elena Peña González, Pilar Corsino Roche, Miren Vicuña Arregui, Ainara Elorza, Manuel Domínguez Cajal, María Chaparro, Manuel Barreiro-de Acosta, Santiago García-LópezVer más
Article information
These are the options to access the full texts of the publication Gastroenterología y Hepatología (English Edition)
Subscriber
Subscribe
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail